Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Treprostinil in Progressive Pulmonary Fibrosis (TETON-PPF)
NCT05943535Phase 3Recruiting
- Sponsor
- United Therapeutics Corporation
- Start
- Oct 2023
- Primary completion
- Nov 2027
- Modality
- Orthosteric Ligands
- Countries
- 15
01
Overview
A Phase 3 trial of treprostinil in pulmonary fibrosis (PF), sponsored by United Therapeutics Corporation. Started Oct 2023; status: recruiting.
02
Drugs
treprostinil
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT05943535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05943535.